Introduction
============

Sarcoidosis is a granulomatous disorder of unknown etiology that affects multiple organ systems. It may present with a wide range of clinical manifestations most frequently involving lungs, lymph nodes, skin, liver, spleen, eyes and parotid glands \[[@b1-cm-93-241]\]. It is more prevalent in females and shows a bimodal age distribution with one peak in the third decade of life and second peak in the fifth decade of life \[[@b2-cm-93-241]--[@b4-cm-93-241]\]. Cutaneous involvement has been reported in approximately 25% cases and most often occurs at disease onset \[[@b5-cm-93-241]--[@b7-cm-93-241]\]. About 25% cases of cutaneous sarcoidosis lesions are limited to the face \[[@b8-cm-93-241],[@b9-cm-93-241]\]. It is a diagnosis of exclusion that is made by identifying granulomatous inflammation in the absence of a known infectious or other cause.

Skin lesions in cutaneous sarcoidosis can be classified into specific and nonspecific. The 'specific' lesions reveal collection of epithelioid histiocytes with no or minimal inflammatory cells called as naked sarcoidal granulomas (NSG) or sarcoidal non-caseating granulomas. The 'non-specific' lesions include erythema nodosum (most common), calcinosis cutis, prurigo and erythema multiforme \[[@b6-cm-93-241]\]. The most common clinical presentation of specific lesions is macules and papules, but plaques, nodules, lupus pernio, subcutaneous infiltrates and infiltration of pre-existing scars are also commonly identified \[[@b10-cm-93-241]--[@b13-cm-93-241]\]. The diagnosis of sarcoidosis is based on clinical, radiologic and histologic evidence of non-caseating granulomas in one or more organ systems with exclusion of other potential diagnosis \[[@b6-cm-93-241]\]. There is limited data in the literature on cutaneous sarcoidosis with respect to Indian scenario. Thus, the present study aims to characterize the clinico-pathological features of cutaneous sarcoidosis and compare it with the literature available.

Methods
=======

The present retrospective study was conducted from January 2010--March 2015 by compiling the data from archival records. The clinical and histopathological features of cutaneous sarcoidosis were evaluated. Clinical charts were retrospectively reviewed to obtain the following data: gender, age at diagnosis, morphology and location of cutaneous lesions, associated symptoms, presence or absence of any extra-cutaneous disease and associated co-morbid conditions. The hematoxylin and eosin-stained slides were reviewed in all the patients. Patterns of granuloma localization (superficial dermis, mid-dermis, deep dermis, and subcutaneous fat) and distribution (peri-vascular, peri-adnexal, perineural and interstitial) were examined. Assessment of additional features including the presence of lymphoid cells, multinucleated giant cells, inclusion bodies, necrosis, fibrosis, foreign material and epidermal changes were noted. Special stains like reticulin, acid fast bacilli (AFB), wade--fite stain and periodic acid Schiff (PAS) were performed wherever required to rule out infectious cause.

Ethics approval
---------------

As anonymized patient reports were used, ethical permission was not required for the study.

Results
=======

The study included fifteen cases, nine (60%) females and six (40%) males, with female to male ratio of 1.5:1. The mean age at diagnosis was 46 years (range: 33 to 65 years). Nodules (46.6%) were the most common morphology of cutaneous lesion, followed by papules (40%), plaque (6.7%) and cystic swelling (6.7%) ([Table I](#tI-cm-93-241){ref-type="table"}). The lesions were limited to head and neck (46.7%), arms (20%), back (13.3) and legs (6.7%). Two patients demonstrated lesions in two or more locations - hand and back and hand, wrist and trunk respectively. Forty six percent of cases showed face involvement. Thirteen percent of cases presented with recurrent forehead swelling. No co-morbid condition was noted in any of the cases.

Radiographic findings were available in 13.3% cases and were within normal limits. Data regarding the laboratory findings including serum angiotensin converting enzyme (ACE) levels and extra-cutaneous manifestation were not available.

Non-caseating, lymphocyte-poor, epithelioid cell granulomas was the predominant finding seen in 86.7% cases. Fibrinoid necrosis was noted in 13.3% cases. Distribution of granulomas was noted in both superficial and deep dermis in all the cases ([Figure 1](#f1-cm-93-241){ref-type="fig"} and [2](#f2-cm-93-241){ref-type="fig"}). Granulomas were seen in the subcutaneous fat (33.3%), peri-adnexal (6.7%) and in perimuscular areas in (6.7%) cases. Characteristics of granulomas are described in [Table II](#tII-cm-93-241){ref-type="table"}.

The density of the lymphocytic infiltrate was mild in 46.6%, moderate in 26.7% and severe in 26.7%. Multinucleated giant cells (mixture of Langhans giant cells and foreign body giant cells) were the most consistent finding seen in all patients, inclusion bodies were seen in 20% and foreign body seen in 6.7% cases. Epidermal changes were seen in 46.6% cases which included epidermal atrophy in 26.7% and other features included parakeratosis, hyperkeratosis, acanthosis, papillomatosis and basal cell vacuolation. Various special stains including AFB, Groccott-Gomori stain and Wade-Fite stain were applied to rule out tubercular granuloma, fungal granuloma and leprosy respectively. Reticulin stain applied showed reticulin rich sarcoidal granulomas in 100% of the cases ([Figure 3](#f3-cm-93-241){ref-type="fig"}).

Discussion
==========

Skin involvement in sarcoidosis is seen in 25% of cases and is most often noted at the onset of the disease process \[[@b5-cm-93-241]--[@b7-cm-93-241]\]. In this study we describe clinical and pathological findings of 15 cases with biopsy confirmed cutaneous sarcoidosis. The mean age at diagnosis was 46 years with female preponderance, which is similar to previous studies \[[@b7-cm-93-241]--[@b9-cm-93-241],[@b14-cm-93-241]\].

Cutaneous manifestations are diverse however, the most common presentations involve erythematous to brown papules, plaques and nodules \[[@b6-cm-93-241]\]. However, in our series the most common presentation was that of nodules. This is in contrast with most of the studies which showed maculopapular eruptions to be the commonest presentation \[[@b5-cm-93-241],[@b6-cm-93-241],[@b15-cm-93-241]\]. Subcutaneous nodules were more frequently seen in females than in male patients. Subcutaneous nodules have also been suggested as an adverse prognostic subtype but as the data in present study regarding presence of extra-cutaneous disease is not available, so this cannot be commented upon \[[@b14-cm-93-241],[@b16-cm-93-241]\]. Facial involvement was around 25% cases of cutaneous sarcoidosis in most studies compared to 33.3% in our study \[[@b8-cm-93-241],[@b9-cm-93-241]\].

With respect to microscopic findings, naked sarcoidal granulomas (NSG) were seen in 86.7% cases, confirming this feature as a sensitive and characteristic histologic finding in cutaneous sarcoidosis \[[@b6-cm-93-241],[@b8-cm-93-241]\]. Reticulin rich NSG were seen in 100% of the cases \[[@b17-cm-93-241]\]. Extensive superficial and deep infiltrate of the dermis was the most common infiltrating pattern.

A range of conditions from infectious processes to reactions to foreign material can show NSG in biopsy but it can be differentiated by clinical findings and special stains.

Recent studies have demonstrated the presence of foreign particles within cutaneous granulomatous lesions in patients with well-established systemic sarcoidosis \[[@b6-cm-93-241],[@b7-cm-93-241],[@b18-cm-93-241]\]. One case in our study showed the presence of foreign body at the site of tattoo which support the hypothesis that foreign material may serve as a nidus for granuloma formation in sarcoidosis. Some studies demonstrated that sarcoidosis can arise in scars, tattoos, surgery or due to long term trauma \[[@b5-cm-93-241],[@b7-cm-93-241],[@b15-cm-93-241],[@b19-cm-93-241],[@b20-cm-93-241]\]. The clinical presentation of our cases did not appear to significantly differ from typical cases of sarcoidosis, because clinically sarcoidosis diagnosis was also suspected, and confirmed on biopsy.

We found focal fibrinoid necrosis in 13.3% of cases which is comparable with other studies available \[[@b7-cm-93-241],[@b8-cm-93-241]\]. Focal necrobiosis associated with granulomas were present in two cases but with clinical correlation, sarcoidosis was considered to be the most likely diagnosis in them.

Asteroid and/or Schaumann bodies were found in only 20% of the biopsies and are considered less sensitive marker for sarcoidosis. Previous studies also indicate that they are a relatively non-specific finding \[[@b21-cm-93-241],[@b22-cm-93-241]\]. Mimickers like tuberculosis, leprosy and other infectious causes were ruled out by special stains like reticulin, AFB, PAS and Wade--Fite stain along with correlation of the clinical findings The granulomas in sarcoidosis cases showed reticulin stain positivity. In our series we did not find any peri-neural granulomas.

Conclusion
==========

The clinical presentation of cutaneous sarcoidosis may be variable. Sarcoidosis should be considered in any patient whose skin biopsy demonstrates granulomatous inflammation without an apparent primary cause. Presence of naked, reticulin rich granulomas is the most characteristic histopathological feature in cutaneous sarcoidosis. Histopathology with clinical history may help reach to a conclusive diagnosis.

![Numerous NSGs in the dermis. Overlying epidermis is atrophied (H&E ×200).](cm-93-241f1){#f1-cm-93-241}

![High power showing numerous lymphocyte poor, non caseating epithelioid cell granulomas in dermis (H&E ×600).](cm-93-241f2){#f2-cm-93-241}

![High power view showing reticulin rich sarcoid granulomas (Reticulin ×600).](cm-93-241f3){#f3-cm-93-241}

###### 

Characteristics of the 15 patients with cutaneous sarcoidosis.

  Characteristics                                                                                  Number (n=15)   Percentage
  ------------------------------------------------------------------------------------------------ --------------- ------------
  Sex                                                                                                              
   Male                                                                                            6               40
   Female                                                                                          9               60
                                                                                                                   
  Age in years (mean)                                                                              46              
                                                                                                                   
   Range                                                                                           33--65          
                                                                                                                   
  Lesion Morphology                                                                                                
                                                                                                                   
   Nodule                                                                                          7               46.6
   Papule                                                                                          6               40
   Plaque                                                                                          1               6.7
   Cystic swelling                                                                                 1               6.7
                                                                                                                   
  Location                                                                                                         
                                                                                                                   
   Head & neck                                                                                     7               46.7
   Arms                                                                                            3               20
   Back/trunk                                                                                      2               13.3
   Leg                                                                                             1               6.7
   Multiple (Lesion at \>2 sites)                                                                  2               13.3
                                                                                                                   
  Symptoms                                                                                                         
                                                                                                                   
   Asymptomatic                                                                                    8               53.3
   Painful                                                                                         4               26.7
   Pruritic                                                                                        3               20
                                                                                                                   
  Recurrent lesions                                                                                2               13.3
  Microscopic findings                                                                                             
                                                                                                                   
   NSG                                                                                             13              86.7
                                                                                                                   
  Fibrinoid necrosis                                                                               2               13.3
  Epithelioid cells                                                                                15              100
                                                                                                                   
   Giant cells                                                                                     15              100
   Inclusion body                                                                                  3               20
   Epidermal changes                                                                               7               46.6
    Atrophy                                                                                        4               26.7
                                                                                                                   
    Other (hyperkeratosis, para-keratosis, acanthosis, papillomatosis and basal cell vacuolation   3               20

###### 

Characteristics of Granulomas.

                           Cellular type   Necrosis   Foreign Body                     
  ------------------------ --------------- ---------- -------------- ---- ---- --- --- ---
  Number of Observations   7               4          4              15   15   2   2   1
